ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Zydus set to market generic anti-diabetic drug
March 15, 2019Zydus receives tentative approval from the USFDA for Sitagliptin and Metformin Hydrochloride Extended-Release tablets -
Zydus Cadila gets USFDA nod to market generic anti-diabetic drug
March 15, 2019The company has received tentative approval from USFDA to market Sitagliptin and Metformin Hydrochloride extended-release tablets in the strength of 50 mg/500 mg, 50 mg/1,000 mg and 100 mg/1,000 mg -
Delhi HC sets aside govt ban on Lupin's anti-diabetic drug Gluconorm-30
February 23, 2019The Delhi High Court on Friday set aside a government notification in which it had banned Lupin's fixed-dose combination (FDC) drug Gluconorm-30, reported Business Standard.
Pharma Sources Insight January 2025
